Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2024-05-20 00:00:00 ET · period of report 2024-05-16 · accession 0001140361-24-026881 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-20 | 2024-05-16 | RCKT | Militello John | See Remarks | S - Sale | $23.35 | -1,079 | 53.3K | -2% | -$25.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-16 | S | D | 1,079 | $23.35 | 53,327 | D | — | — | (F1) The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs. |